U.S. Markets closed

Most Analysts Are Optimistic on Alexion Pharmaceuticals

Margaret Patrick
Most Analysts Are Optimistic on Alexion Pharmaceuticals

How Major Rare Disease Pharma Stocks Are Positioned in MarchAnalysts’ recommendations and target priceWall Street analysts expect a potential upside of 21.63% for Alexion Pharmaceuticals (ALXN) based on the stock’s closing price on March 21.